Form 144 | RxSight(RXST.US) Officer Proposes to Sell 2.4 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 3, $RxSight(RXST.US)$ Officer Kurtz Ronald M MD intends to sell 40,000 shares of its common stock on May 3, with a total market value of approximately $2.4 million. Sour
moomoo NewsMay 3 11:52 ET
RxSight(RXST.US) Officer Sells US$526.91K in Common Stock
$RxSight(RXST.US)$ Officer Thunen Shelley B sold 10,000 shares of common stock on May 1, 2024 at an average price of $52.6913 for a total value of $526.91K.Source: Announcement What is statement of ch
moomoo NewsMay 2 17:40 ET
Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing
Shelley B Thunen, Chief Financial Officer, on May 01, 2024, sold 10,000 shares in Rxsight (RXST) for $526,913. Following the Form 4 filing with the SEC, Thunen has control over a total of 22,340 share
MT NewswiresMay 2 17:03 ET
Form 144 | RxSight(RXST.US) Officer Proposes to Sell 526.91K in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $RxSight(RXST.US)$ Officer SHELLEY B THUNEN intends to sell 10,000 shares of its common stock on May 1, with a total market value of approximately $526.91K. SHELLEY B
moomoo NewsMay 1 16:38 ET
RxSight, Inc. to Present at the Bank of America Healthcare Conference
ALISO VIEJO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced
GlobeNewswireMay 1 16:05 ET
Should You Investigate RxSight, Inc. (NASDAQ:RXST) At US$52.84?
Yahoo FinanceApr 25 12:19 ET
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
ALISO VIEJO, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
GlobeNewswireApr 22 16:05 ET
Companies Like RxSight (NASDAQ:RXST) Can Afford To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. Indeed, RxSight (NASDAQ:RXST) stock is up 197% in the last year, providing strong gains for shareholders. But while
Simply Wall StApr 19 07:14 ET
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Seeking AlphaApr 14 17:56 ET
Assessing RxSight: Insights From 8 Financial Analysts
RxSight (NASDAQ:RXST) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.Summarizing their recent assessments, the table below illustrates
BenzingaApr 11 08:00 ET
Express News | Needham Reiterates Buy on RxSight, Maintains $64 Price Target
Moomoo 24/7Apr 11 05:55 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), RxSight (RXST) and Clearside Biomedical (CLSD)
TipRanksApr 11 05:50 ET
RxSight Announces Commercial Launch of Its Newest Light Adjustable Lens, the LAL+, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
ALISO VIEJO, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
GlobeNewswireApr 4 16:05 ET
RxSight(RXST.US) Officer Sells US$997.95K in Common Stock
$RxSight(RXST.US)$ Officer Thunen Shelley B sold 20,000 shares of Common Stock on Apr 1, 2024 at an average price of $49.8973 for a total value of $997.95K.Source: Announcement What is statement of ch
moomoo NewsApr 2 17:02 ET
Rxsight Insider Sold Shares Worth $997,946, According to a Recent SEC Filing
Shelley B Thunen, Chief Financial Officer, on April 01, 2024, sold 20,000 shares in Rxsight (RXST) for $997,946. Following the Form 4 filing with the SEC, Thunen has control over a total of 22,093 sha
MT NewswiresApr 2 16:21 ET
Form 144 | RxSight(RXST.US) Officer Proposes to Sell 996.33K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 1, $RxSight(RXST.US)$ Officer Thunen Shelley B intends to sell 20,000 shares of its common stock on Apr 1, with a total market value of approximately $996.33K. Source: A
moomoo NewsApr 1 16:25 ET
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
ALISO VIEJO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
GlobeNewswireMar 27 16:05 ET
Is RxSight, Inc. (NASDAQ:RXST) Potentially Undervalued?
While RxSight, Inc. (NASDAQ:RXST) might not have the largest market cap around , it led the NASDAQGM gainers with a relatively large price hike in the past couple of weeks. The company is inchin
Simply Wall StMar 6 07:27 ET
RxSight(RXST.US) Officer Sells US$563.73K in Common Stocks
$RxSight(RXST.US)$ Officer Thunen Shelley B sold 10,000 shares of Common Stocks on Mar 1, 2024 at an average price of $56.3726 for a total value of $563.73K.Source: Announcement What is statement of c
moomoo NewsMar 5 16:47 ET
Patrick Wood Reaffirms Buy Rating for RxSight Amid Strong Growth and Market Expansion Potential
TipRanksMar 4 14:05 ET
No Data
No Data